PharmaIN
Manufacturing · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11812 N Creek Pkwy N Ste 101, Bothell, W...Phone Number
(206) 568-1450Website
www.pharmain.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
1
1
1
About PharmaIN
PharmaIN Corporation is a clinical stage biopharmaceutical company specializing in the development of first- and best-in-class subcutaneous therapies for liver disease and cancer through innovative peptide engineering. The company focuses on creating novel treatments for patients with advanced liver cirrhosis and aims to improve their quality of life with self-injectable therapies. PharmaIN is currently advancing its lead product, PHIN-214, through clinical trials and is actively seeking strategic partnerships for further development. Their commitment lies in enabling patients to manage their health more effectively and independently.Explore more
PharmaIN Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PharmaIN your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once PharmaIN has new funding data
Earning: See what the market has to say on PharmaIN recently announced quarterly report
Product Launch: Get notified when PharmaIN launches new products
Check if PharmaIN has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
PharmaIN, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if PharmaIN is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if PharmaIN had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at PharmaIN
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to PharmaIN
Compare insights from companies similar to PharmaIN, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PharmaIN is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
PharmaIN is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about PharmaIN.
PharmaIN financials insights
Gather financial insights about PharmaIN, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Private Equity
$1.5M
2020
Debt
$150K
PharmaIN Tech Stack
A closer look at the technologies used by PharmaIN
See more technologies
Most Recent Scoops
Funding
Project
Spending/Investment, Funding
Open Position
Open Position
Funding
Project
Funding
Project
Award, Spending/Investment
PharmaIN News & Media
PharmaIN to Present Promising Interim Data from its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at The Liver Meeting® 2024
PharmaIN Corporation is set to present promising data from its ongoing Phase 1 trial of PHIN-214, an optimized vasopressor therapy for decompensated cirrhosis, at The Liver Meeting® 2024. BOTHELL, Wash., Oct. 16, 2024 /PRNewswire-PRWeb/ -- PharmaIN Corporation, a clinical-stage...PharmaIN's dCNP Therapy Shows Promise in Normalizing Tumor Blood Vessels and Reinvigorating Immune Response in Solid Tumor Models.
PharmaIN Corporation has published promising research in Science Translational Medicine on their novel therapy, dCNP, which shows encouraging preclinical results against challenging cancers like colon and pancreatic adenocarcinomas. By normalizing tumor blood vessels, dCNP improves...PeptiDream Announces Strategic Partnership with Drug-Delivery Expert PharmaIN
KANAGAWA, Japan and BOTHELL, Wash., June 5, 2019 /PRNewswire/ -- PeptiDream Inc., a public Kanagawa-based biopharmaceutical company ("PeptiDream")(TOKYO:4587) announced today a strategic partnership with Seattle-based PharmaIN Corporation ("PharmaIN") for the purpose of investigating the...PharmaIN and Shionogi Announce Collaboration and $17M Securities Purchase Agreements
BOTHELL, Wash. and OSAKA, Japan, Jan. 5, 2018 /PRNewswire/ -- PharmaIN Corporation and Shionogi & Co., LTD announced today that they entered into a Collaboration Agreement with an exclusive two-year Option to negotiate a License for the collaboration product. Shion...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PharmaIN
Sign Up For FreeTo access detailed company insights
PharmaIN Corporation is a clinical stage biopharmaceutical company specializing in the development of first- and best-in-class subcutaneous therapies for liver disease and cancer through innovative peptide engineering. The company focuses on creating novel treatments for patients with advanced liver cirrhosis and aims to improve their quality of li... Read More
